| 000 | 01011 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517014129.0 | ||
| 264 | 0 | _c20160329 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1529-8019 | ||
| 024 | 7 |
_a10.1111/dth.12198 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYancey, Kim B | |
| 245 | 0 | 0 |
_aCommentary regarding clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study. _h[electronic resource] |
| 260 |
_bDermatologic therapy _c |
||
| 300 |
_a174-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aDermatologic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPemphigus _xdrug therapy |
| 650 | 0 | 4 |
_aRituximab _xadministration & dosage |
| 773 | 0 |
_tDermatologic therapy _gvol. 28 _gno. 3 _gp. 174-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dth.12198 _zAvailable from publisher's website |
| 999 |
_c24583783 _d24583783 |
||